If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
437.00    0.00 (0.00%)
Bid:
436.50
Ask:
445.00
Spread: 8.50 (1.947%)
Market Cap: £214.92m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Re Agreement

21 Mar 2006 14:37

Zotefoams PLC21 March 2006 21 March 2006 Commercial agreement between Zotefoams plc ("Zotefoams") and Sekisui ChemicalCompany Limited and its subsidiaries ("Sekisui Group") With immediate effect, Zotefoams and Sekisui Group have agreed to terminatetheir commercial agency relationships in Europe and North America. Sekisui willcontinue to act as distributor for Zotefoams' products in Asia until 30 April2006. During 2000 and 2001 Zotefoams entered into a number of worldwide sales andmarketing alliances for polyolefin foams with Sekisui Group, who act asexclusive agent and distributor for Zotefoams in Continental Europe (throughtheir European subsidiary, Alveo AG ("Alveo")) and Asia respectively. SekisuiGroup also act as an agent for certain of Zotefoams' customers in North Americathrough its American subsidiary, Voltek LLC. On 15 December 2005 and on 14 March 2006, Zotefoams announced that it had, forsome time, been in negotiations with Sekisui Group in relation to certain of itsobligations under two of these agreements. Zotefoams announced that while it wasstill open to a resolution by other means, it had instigated arbitrationproceedings. Termination of these arrangements was agreed subject to Zotefoams plc payingAlveo a reduced termination fee of euro 1.4 million as well as dropping alldisputes due to be heard in arbitration. Zotefoams will assume directresponsibility for all customer matters in all regions with plans to increasedirect sales resource to support this, although it is envisaged separateagreements may be appropriate in Asia in the medium term. In 2005, Zotefoams paid Sekisui Group approximately euro 1.5 million in agent'scommissions (principally to Alveo) under these arrangements. From 20 March 2006,no further commissions will be earned by Sekisui Group. Zotefoams is pleased that these disputes have been resolved with Sekisui andlooks forward to working directly with its customers. Enquiries: Zotefoams plc 0208-664-1600David Stirling, Managing DirectorClifford Hurst, Finance Director Financial Dynamics Limited 0774-602-739 / 0207-831-3113Sarah MacLeod / Deborah Scott This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Jul 20224:36 pmRNSPrice Monitoring Extension
12th Jul 202212:39 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSNotice of Results
30th Jun 20224:52 pmRNSDirector/PDMR Shareholding
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
8th Jun 20228:49 amRNSDirector/PDMR Shareholding
26th May 20224:41 pmRNSSecond Price Monitoring Extn
26th May 20224:36 pmRNSPrice Monitoring Extension
25th May 20221:04 pmRNSResult of the 2022 Annual General Meeting
25th May 20227:00 amRNSTrading Update
18th May 20224:41 pmRNSSecond Price Monitoring Extn
18th May 20224:36 pmRNSPrice Monitoring Extension
12th May 20223:58 pmRNSDirector/PDMR Shareholding
11th May 20222:13 pmRNSDirector/PDMR Shareholding
25th Apr 20225:16 pmRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNS2021 Annual Report and Notice of the 2022 AGM
11th Apr 20223:49 pmRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSPreliminary Results
14th Mar 202212:30 pmRNSDirector/PDMR Shareholding
25th Feb 20227:00 amRNSNotice of results and investor presentation
15th Feb 20224:26 pmRNSDirector/PDMR Shareholding
27th Jan 20227:00 amRNSFull Year Trading Update
12th Jan 202211:12 amRNSDirector/PDMR Shareholding
23rd Dec 20211:56 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSTrading Update
14th Dec 202111:55 amRNSDirector/PDMR Shareholding
12th Nov 202112:41 pmRNSDirector/PDMR Shareholding
10th Nov 20215:48 pmRNSHolding(s) in Company
4th Nov 20215:59 pmRNSHolding(s) in Company
4th Nov 20213:31 pmRNSDirector/PDMR Shareholding
3rd Nov 20217:00 amRNSQ3 Trading Update
15th Oct 202112:10 pmRNSDirector/PDMR Shareholding
12th Oct 202111:05 amRNSDirector/PDMR Shareholding
1st Oct 20213:31 pmRNSHolding(s) in Company
14th Sep 202110:05 amRNSDirector/PDMR Shareholding
12th Aug 20212:28 pmRNSDirector/PDMR Shareholding
10th Aug 20217:00 amRNSInterim Results
19th Jul 20219:26 amRNSNotice of Results
13th Jul 20211:59 pmRNSDirector/PDMR Shareholding
14th Jun 20213:06 pmRNSDirector/PDMR Shareholding
14th Jun 202111:35 amRNSDirector/PDMR Shareholding
10th Jun 20214:41 pmRNSDirector/PDMR Shareholding
9th Jun 20213:48 pmRNSDirector/PDMR Shareholding
2nd Jun 20213:49 pmRNSHolding(s) in Company
26th May 202112:08 pmRNSResult of AGM
26th May 20217:00 amRNSTrading Update
12th May 20213:44 pmRNSDirector/PDMR Shareholding
28th Apr 20212:05 pmRNSDirector/PDMR Shareholding
26th Apr 20213:16 pmRNS2020 Annual Report, Notice of the 2021 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.